Form D · Pharmaceuticals

INOTEK PHARMACEUTICALS CORP

Lexington, MA · CIK 0001281895

Offering snapshot reported Jul 19, 2011 · SEC filing

Reported sold: $23.6M
Investors reported: 11
Minimum accepted: $0
First sale: Jun 9, 2010

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$14,250,000 → $23,600,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jul 19, 2011	Amendment	$23,600,000	$9,350,000vs Jun 23, 2010	11	SEC filing
Jun 23, 2010	Initial	$14,250,000	No comparison	11	SEC filing
Sep 10, 2007	Paper	Not reported	No comparison	Not reported	SEC filing
Aug 23, 2005	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Equity
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-143912

Source: Form D, filed Jul 19, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Rudolf A. Baumgartner, Md	Executive
James G. Ham, Iii	Executive
Ittai Harel	Director
Paul G. Howes	Director, Executive
Argeris ("Jerry") N. Karabelas, Ph D	Director
John Leaman	Director
Maggie Flanagan Le Flore, Ph D	Director
Michael D. Loberg, Ph D	Director
William K. Mc Vicar, Ph.D.	Executive
Atul Saran	Director
Martin Vogelbaum	Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

33 Hayden Avenue 2 Nd Floor
Lexington, MA, 02421